45
Participants
Start Date
April 30, 2011
Primary Completion Date
December 31, 2011
Study Completion Date
January 31, 2012
Limicol
3 tablets (Limicol) + 3 tablets (Placebo) / day during 1 month and follow-up 1 month without treatment
Limicol
6 tablets (Limicol) / day during 1 month and follow-up 1 month without treatment
Placebo
6 tablets (Placebo) / day during 1 month and follow-up 1 month without treatment
Biofortis, Nantes
Lead Sponsor
Collaborators (1)
BioFortis
OTHER
Lescuyer Laboratory
INDUSTRY